{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "regularMarketChangePercent": 24.542131, "regularMarketPrice": 0.034, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.09, "sharesOutstanding": 161515008, "fiftyDayAverage": 0.035466, "fiftyDayAverageChange": -0.0014659986, "fiftyDayAverageChangePercent": -0.041335322, "twoHundredDayAverage": 0.0741035, "twoHundredDayAverageChange": -0.040103495, "twoHundredDayAverageChangePercent": -0.5411822, "marketCap": 7260564, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1596693600000, "priceHint": 4, "marketState": "REGULAR", "exchange": "FRA", "shortName": "ISOFOL MEDICAL AB", "longName": "Isofol Medical AB (publ)", "messageBoardId": "finmb_47549518", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChange": 0.0067000017, "regularMarketTime": 1683892037, "regularMarketDayHigh": 0.034, "regularMarketDayRange": "0.024 - 0.034", "regularMarketDayLow": 0.024, "regularMarketVolume": 10000, "regularMarketPreviousClose": 0.0273, "bid": 0.0341, "ask": 0.067, "fullExchangeName": "Frankfurt", "financialCurrency": "SEK", "regularMarketOpen": 0.024, "averageDailyVolume3Month": 169, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.013800003, "fiftyTwoWeekLowChangePercent": 0.6831685, "fiftyTwoWeekRange": "0.0202 - 0.888", "fiftyTwoWeekHighChange": -0.85400003, "fiftyTwoWeekHighChangePercent": -0.96171176, "fiftyTwoWeekLow": 0.0202, "fiftyTwoWeekHigh": 0.888, "symbol": "5IU.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Biotech Center", "address2": "Arvid Wallgrens Backe 20", "city": "Gothenburg", "zip": "413 46", "country": "Sweden", "phone": "46 3 17 97 22 80", "website": "https://isofolmedical.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Isofol Medical AB (publ), a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally. The company develops arfolitixorin, which is in phase 3 clinical trial for the treatment of advanced colorectal cancer. It has strategic collaborations with Recipharm. The company was incorporated in 2008 and is headquartered in Gothenburg, Sweden.", "fullTimeEmployees": 13, "companyOfficers": [{"maxAge": 1, "name": "Mr. Thomas  Andersson Ph.D.", "age": 70, "title": "Chief Exec. Officer", "yearBorn": 1952, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Roy  Jonebrant", "title": "Acting Chief Financial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Roger  Tell M.D., Ph.D.", "age": 57, "title": "Chief Medical Officer, Chief Scientific Officer & Sr. VP of Clinical Devel.", "yearBorn": 1965, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}